|MKEA -- France Stock|| |
EUR 2.61 0.01 0.38%
Mr. Alexandre Loiseau has served as a Chief Executive Officer and Director at Mauna Kea Technologies SA since May 2000. He started his career at the National Center for Space Studies in Toulouse and at the Paris Observatory then joined NASA Jet Propulsion Laboratory in Pasadena California as a research scientist. He is a graduate of Ecole Polytechnique and holds a Ph.D. in Astrophysics and Optical Instrumentation.
CEO Since 2000 Ph.D
33 1 48 24 03 45 http://www.maunakeatech.com
The company has return on total asset (ROA)
of (25.43) %
which means that it has lost $25.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (73.44) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 6.95 M in total debt with debt to equity ratio (D/E) of 41.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mauna Kea Technologies SA has Current Ratio of 5.67 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Mauna Kea Technologies SA, a medical device company, develops and sells endomicroscopy and optical biopsy for the diagnosis and treatment of cancer and other diseases. The company was founded in 2000 and is headquartered in Paris, France. Mauna Kea operates under Medical Devices classification in France and traded on Paris Stock Exchange. It employs 90 people.Mauna Kea Technologies SA (MKEA) is traded on Paris Stock Exchange in France. It is located in 9, rue d'Enghien and employs 90 people.
Mauna Kea Technologies Leadership Team
|Olivier Regnard, Deputy CEO, CFO|
|Bertrand Talhouet, Representative of Creadev on the Board of Directors|
|Eric Cohen, CFO and VP of Fin.|
|Gilles Brisson, Chairman, Independent Director|
|Alexandre Loiseau, CEO, Director|
|Guillaume Bailliard, President for North America|
|Christopher McFadden, Director|
|Francois Lacombe, Chief Scientific Officer|
|Christopher Tihansky, Chief Devel. Officer and President of North America|
|JeanLuc Boulnois, Director|
|Bruno Villaret, Vice President of International Sales|
|Joseph DeVivo, Non-Executive Independent Director|
|Christophe Bailleul, Vice-President Clinical Affairs, Health Economics and Market Access|
|Agnes Rouffiac, Director of Human Resources|
|Veronique Dentan, Director of Operations|
|Sebastien Cadet, Global Director of Marketing and OEM Leader|
|Sacha Loiseau, Founder, CEO and Director|
|Molly ONeill, Director|
|Pierre Forest, COO|
|John Soto, COO|
|Marie Meynadier, Director|
Stock Performance Indicators
Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Mauna Kea Technologies SA. What is your trading attitude regarding investing in Mauna Kea Technologies SA? Are you bullish or bearish?
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations